SUSCEPTIBILITY OF CONGENITALLY IMMUNODEFICIENT MICE TO A NONENCAPSULATED STRAIN OF CRYPTOCOCCUS-NEOFORMANS

被引:13
作者
SALKOWSKI, CA [1 ]
BALISH, E [1 ]
机构
[1] UNIV WISCONSIN,SCH MED,DEPT MED MICROBIOL & IMMUNOL,MADISON,WI 53706
关键词
CRYPTOCOCCUS-NEOFORMANS; CAPSULE; IMMUNODEFICIENT MICE;
D O I
10.1139/m91-144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The susceptibility of congenitally immunodeficient mice to a nonencapsulated strain of Cryptococcus neoformans (strain M7) was evaluated. Gnotobiotic mice with defined congenital defects in innate immunity (beige) or cell-mediated immunity (athymic) or with combined defects in innate and cellular immunity (beige athymic) were i.v. challenged with C neoformans M7. The nonencapsulated strain of C neoformans produced a persistant low-grade infection in the brains of all immunodeficient and immunocompetent mice used in this study. Immunocompetent mice (nu/+;bg/+) and immunodeficient bg/bg mice readily cleared nonencapsulated cryptococci from their kidneys, liver, lungs, and spleen. In contrast to nu/+ mice, nu/nu mice had a reduced capacity to clear nonencapsulated cryptococci from their kidneys and liver after i.v. challenge. Both bg/bg-nu/nu and bg/bg-nu/+ mice developed a low-grade infection in their kidneys, liver, lungs, and spleen, which was maintained throughout the 21-day study. Persistent infections were not due to reversion to an encapsulated state. These data indicate that a capsule may not always be necessary for C neoformans to survive, in vivo, in tissues of immunodeficient and immunocompetent mice.
引用
收藏
页码:834 / 839
页数:6
相关论文
共 27 条
[1]   CORRELATES OF CELL-MEDIATED-IMMUNITY IN CANDIDA-ALBICANS-COLONIZED GNOTOBIOTIC MICE [J].
BALISH, E ;
FILUTOWICZ, H ;
OBERLEY, TD .
INFECTION AND IMMUNITY, 1990, 58 (01) :107-113
[2]   THE EFFECT OF MICROBIAL-FLORA, DIET, AND AGE ON THE TUMORICIDAL ACTIVITY OF NATURAL-KILLER CELLS [J].
BARTIZAL, KF ;
SALKOWSKI, C ;
PLEASANTS, JR ;
BALISH, E .
JOURNAL OF LEUKOCYTE BIOLOGY, 1984, 36 (06) :739-750
[3]   POORLY ENCAPSULATED CRYPTOCOCCUS-NEOFORMANS FROM PATIENTS WITH AIDS .2. CORRELATION OF CAPSULE SIZE OBSERVED DIRECTLY IN CEREBROSPINAL-FLUID WITH THAT AFTER ANIMAL PASSAGE [J].
BOTTONE, EJ ;
WORMSER, GP .
AIDS RESEARCH, 1986, 2 (03) :219-225
[4]   POORLY ENCAPSULATED CRYPTOCOCCUS-NEOFORMANS FROM PATIENTS WITH AIDS .1. PRELIMINARY-OBSERVATIONS [J].
BOTTONE, EJ ;
TOMA, M ;
JOHANSSON, BE ;
WORMSER, GP .
AIDS RESEARCH, 1986, 2 (03) :211-218
[5]   CRYPTOCOCCUS NEOFORMANS .I. NONENCAPSULATED MUTANTS [J].
BULMER, GS ;
SANS, MD ;
GUNN, CM .
JOURNAL OF BACTERIOLOGY, 1967, 94 (05) :1475-&
[6]   RESPONSE OF CONGENITALLY ATHYMIC (NUDE) AND PHENOTYPICALLY NORMAL MICE TO CRYPTOCOCCUS-NEOFORMANS INFECTION [J].
CAULEY, LK ;
MURPHY, JW .
INFECTION AND IMMUNITY, 1979, 23 (03) :644-651
[7]  
Chandler F W, 1985, Curr Top Med Mycol, V1, P1
[8]   CAPSULE SIZE OF CRYPTOCOCCUS-NEOFORMANS - CONTROL AND RELATIONSHIP TO VIRULENCE [J].
DYKSTRA, MA ;
FRIEDMAN, L ;
MURPHY, JW .
INFECTION AND IMMUNITY, 1977, 16 (01) :129-135
[9]   DECREASED VIRULENCE IN STABLE, ACAPSULAR MUTANTS OF CRYPTOCOCCUS-NEOFORMANS [J].
FROMTLING, RA ;
SHADOMY, HJ ;
JACOBSON, ES .
MYCOPATHOLOGIA, 1982, 79 (01) :23-29
[10]  
GAL AA, 1986, ARCH PATHOL LAB MED, V110, P502